What Patients Should Discuss with Their Doctor Patients should discuss confirmed liver disease status, FIB-4 fibrosis risk score, metabolic comorbidities, and clinical trial eligibility with their GP or specialist before drawing conclusions about retatrutide's relevance to their care
If needed, get up and read a little bit, meditate and/or do some yoga
This shift and the agendas being pushed forward also include more stigma around weight and fat phobia, which aligns with the incorrect societal belief that fat equals bad and thin equals good
1718-1730, Li, Guangqi, et al
Semaglutide provides weight loss results two times more effective than other approaches and is quickly becoming the most prescribed weight loss medication
And inside all of that excitement sits one awkward, unavoidable truth that keeps coming up: weight loss caused by GLP-1s often includes muscle loss, not just fat loss